Filing Flows › Camp4 Therapeutics (CAMP) › Q2 2026 › vs Q1 2026
Camp4 Therapeutics (CAMP) Q2 2026 vs Q1 2026 (quarter over quarter)
Camp4 Therapeutics's revenue rose $485K (+37%) from $1.3M in Q1 2026 to $1.8M in Q2 2026.
Camp4 Therapeutics, Q2 2026: revenue $1.8M (+19% year over year), operating margin -752.1%, net loss $33.5M, operating cash flow −$12.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $1.3M | $485K | +37% |
| Net loss | $33.5M | $18.3M | $15.2M | +83% |
| Costs & expenses | $35.3M | $19.6M | $15.7M | +80% |
| Operating costs | $15.2M | $14.4M | $794K | +6% |
| Interest & other, net | $20.1M | $5.3M | $14.9M | +283% |
| Research & development | $10.8M | $10.2M | $657K | +6% |
| General & admin | $4.3M | $4.2M | $137K | +3% |
| Operating cash sources | $33.5M | $18.3M | $15.2M | +83% |
| Depreciation & amortization | $515K | $520K | −$5K | -1% |
| Share-based compensation | $1.9M | $1.5M | $459K | +31% |
| Working capital & other | $18.4M | $5.4M | $13.0M | +243% |
| Cash used in operations | $12.7M | $11.0M | $1.7M | +16% |
| Net loss absorbed | $33.5M | $18.3M | $15.2M | +83% |
Questions
How much did Camp4 Therapeutics's revenue grow quarter over quarter in Q2 2026?
Camp4 Therapeutics's revenue rose $485K (+37%) from $1.3M in Q1 2026 to $1.8M in Q2 2026.